2,3-piperidinedicarboxylic acid has been researched along with Cranial Nerve II Diseases in 1 studies
2,3-piperidinedicarboxylic acid: effective antagonist at all three types of excitatory amino acid receptors; does not depress responses to acetylcholine or substance P
Excerpt | Relevance | Reference |
---|---|---|
"To determine whether anterior ischemic optic neuropathy and compressive optic neuropathy in humans alter the photopic flash ERG and to investigate the cellular origins of the waves that are affected by pharmacologic agents in primates." | 1.32 | Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina. ( Bahrani, HM; Dorotheo, EU; Frishman, LJ; Rangaswamy, NV; Schiffman, JS; Tang, RA, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rangaswamy, NV | 1 |
Frishman, LJ | 1 |
Dorotheo, EU | 1 |
Schiffman, JS | 1 |
Bahrani, HM | 1 |
Tang, RA | 1 |
1 other study available for 2,3-piperidinedicarboxylic acid and Cranial Nerve II Diseases
Article | Year |
---|---|
Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina.
Topics: Adult; Aged; Animals; Electroretinography; Female; Glaucoma, Open-Angle; Humans; Light; Macaca mulat | 2004 |